
| Salt Composition: | Glimepiride (2mg) + Metformin (500mg) + Voglibose (0.mg) |
| Manufacturer: | Medmerus Life Sciences |
| Storage: | Below 25 degree celcius |
Out of Stock
Have doubts about this medicine?
Have doubts about this medicine?
Glipmate MV 2mg/500mg/0.2mg Tablet is an anti-diabetic drug used to treat type 2 diabetes mellitus in adults by controlling blood sugar levels. Glipmate MV 2mg/500mg/0.2mg Tablet belongs to a category of medicines known as anti-diabetic drugs. It is a combination of medicines used to treat type 2 diabetes mellitus in adults. It helps control blood sugar levels in people with diabetes. The medicine should be taken with food to avoid an upset stomach and can cause hypoglycemia when used with other antidiabetic medicines, alcohol, or if a meal is delayed or missed. Regular liver function checks may be necessary, and any symptoms like abdominal pain, loss of appetite, or jaundice should be reported to a doctor.
Glipmate MV 2mg/500mg/0.2mg Tablet is a combination of three antidiabetic medicines.
What is Glipmate MV 2mg/500mg/0.2mg Tablet?
Glipmate MV 2mg/500mg/0.2mg Tablet is a combination medication containing Glimepiride, Metformin and Voglibose. This medicine is used to treat type 2 diabetes mellitus (DM). It improves blood glucose levels in adults when taken with diet and exercise as directed. Glimepiride increases insulin release from the pancreas, metformin reduces glucose production by the liver and improves insulin sensitivity. Voglibose is an alpha-glucosidase inhibitor that lowers postprandial (after meals) glucose levels. This combination is not suitable for the treatment of type 1 DM.
What are the possible side effects of Glipmate MV 2mg/500mg/0.2mg Tablet?
Possible side effects include hypoglycemia (low blood sugar), nausea, diarrhea, altered taste, flatulence, stomach pain, headache, skin rash and respiratory tract infection. It's important to monitor for potential side effects.
Are there any specific conditions in which Glipmate MV 2mg/500mg/0.2mg Tablet should not be taken?
The use of Glipmate MV 2mg/500mg/0.2mg Tablet should be avoided in individuals with known allergies to any components or excipients in this medication, as well as those with moderate to severe kidney disease, inflammatory bowel disease, colonic ulcers and underlying metabolic acidosis including diabetic ketoacidosis.
Is it safe to take alcohol while I am also taking Glipmate MV 2mg/500mg/0.2mg Tablet?
No, combining Glipmate MV 2mg/500mg/0.2mg Tablet with alcohol is not recommended. This combination can lower blood sugar levels (hypoglycemia) and increase the risk of lactic acidosis.
Can the use of Glipmate MV 2mg/500mg/0.2mg Tablet cause hypoglycemia?
Yes, using Glipmate MV 2mg/500mg/0.2mg Tablet can lead to hypoglycemia (low blood sugar level). Symptoms include nausea, headache, irritability, hunger, sweating, dizziness, fast heart rate and feeling anxious or shaky. This is more likely if you miss meals, drink alcohol, over-exercise, or take other antidiabetic medications alongside it. Regular monitoring of blood glucose levels is essential. Always keep glucose tablets, honey, or fruit juice readily available.
What are the instructions for the storage and disposal of Glipmate MV 2mg/500mg/0.2mg Tablet?
Store this medicine in its original container, tightly sealed. Refer to the accompanying packaging or label for specific storage instructions. Ensure unused medication is disposed of properly; it should not be consumed by pets, children, or others.
Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush, or break it. Glipmate MV 2mg/500mg/0.2mg Tablet is to be taken on an empty stomach.
Alcohol
It is unsafe to consume alcohol with Glipmate MV 2mg/500mg/0.2mg Tablet.
Breastfeed
Glipmate MV 2mg/500mg/0.2mg Tablet is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.
Pregnancy
Glipmate MV 2mg/500mg/0.2mg Tablet may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.